Abstract:Sepsis-associated encephalopathy (SAE) is a collection of clinical syndromes resulting from sepsis and characterized by widespread brain dysfunction. The high prevalence of SAE has adverse outcomes on the clinical management and prognosis of sepsis patients. However, currently, there are no effective treatments to ameliorate SAE. The pathogenesis of SAE is complex, including neuroinflammation and microglia activation, destruction of the blood-brain barrier (BBB), neurotransmitter dysfunction, cerebral metabolism and mitochondrial impairment, accumulation of amyloid beta and tauopathy, complement activation, among others. Furthermore, these mechanisms intertwine with each other, further complicating the comprehension of SAE. Among them, neuroinflammation mediated by hyperactivated microglia is considered the primary etiology of SAE. This instigates a detrimental cycle wherein BBB permeability escalates, facilitating direct damage to the central nervous system (CNS) by various neurotoxic substances. Activation of the NLRP3 inflammasome, situated within microglia, can be triggered by diverse danger signals, leading to cell pyroptosis, apoptosis, and tauopathy. These complex processes intricately regulate the onset and progression of neuroinflammation. In this review, we focus on elucidating the inhibitory regulatory mechanism of the NLRP3 inflammasome in microglia, which ultimately manifests as suppression of the inflammatory response. Our ultimate objective is to augment comprehension regarding the role of microglial NLRP3 inflammasome as we explore potential targets for therapeutic interventions against SAE.

Sepsis-associated encephalopathy: a vicious cycle of immunosuppression

Septic Encephalopathy: when Cytokines Interact with Acetylcholine in the Brain.

Neuroimmune Regulation in Sepsis-Associated Encephalopathy: The Interaction Between the Brain and Peripheral Immunity

ROLE OF MICROGLIA IN SEPSIS-ASSOCIATED ENCEPHALOPATHY PATHOGENESIS: AN UPDATE

Metabolic Reprogramming of Microglia in Sepsis-Associated Encephalopathy: Insights from Neuroinflammation

Neuroendocrine immune network and sepsis

Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies

The Advance of Pathogenesis of Sepsis-Associated Encephalopathy

Breaking the vicious cycle: Targeting the NLRP3 inflammasome for treating sepsis-associated encephalopathy

The Key Drivers of Brain Injury by Systemic Inflammatory Responses after Sepsis: Microglia and Neuroinflammation

The biological alterations of synapse/synapse formation in sepsis-associated encephalopathy

Research progress in the pathogenesis of sepsis-associated encephalopathy

Diagnosis and Pathophysiology of Septic-Associated Encephalopathy

Sepsis Impairs Purkinje Cell Functions and Motor Behaviors Through Microglia Activation

Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy

Basic research and clinical progress of sepsis-associated encephalopathy

Sepsis-associated encephalopathy: Autophagy and miRNAs regulate microglial activation

Application background and mechanism of short-chain fatty acids in sepsis-associated encephalopathy

The role of the peripheral system dysfunction in the pathogenesis of sepsis-associated encephalopathy

[Research progress on the role of microglia in sepsis-associated encephalopathy]

Sepsis-Associated Encephalopathy: A Mini-Review of Inflammation in the Brain and Body